New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
Shape
US Flag

PNK

EPS improving

EPS improving

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 23 Oct 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 23 Oct 2024

1.13USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 22, 2024
1W 0.00 % 1M 0.89 % 3M 45.35 % 1Y 294.81 %

Key Metrics

Shape
  • Market Cap

    1.15B


  • Shares Outstanding

    1.02B


  • Share in Float

    690.36M


  • Dividende

    0.04


  • Earning Date

    23 Oct 2024


  • Price Target

    1.13


  • Average Volume

    319


  • Beta

    0.549


  • Range

    0.7265-1.13


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.genommalab.com


  • Sector

    Healthcare


Fundamentals

Shape

15.00x

P/E Ratio

1.19x

P/S Ratio

1.85x

P/B Ratio

0.6

Debt/Equity

7.4%

Net Margin

$0.1

EPS

How GNMLF compares to sector?

P/E Ratio

Relative Strength

Shape

GNMLF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$942M

Shape271%

2025-Revenue

$0.12

Shape225%

2025-EPS

$196M

Shape17%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+3%

0.4
vs 0.39

Q4.22

arrow
arrow

-25%

0.27
vs 0.36

Q1.23

arrow
arrow

-94%

0.02
vs 0.34

Q2.23

arrow
arrow

-94%

0.03
vs 0.4

Q3.23

arrow
arrow

-94%

0.02
vs 0.4

Q4.23

arrow
arrow

N/A

-0.01
vs 0.27

Q1.24

arrow
arrow

+15%

0.02
vs 0.02

Q2.24

arrow
arrow

+43%

0.04
vs 0.03

Q3.24

arrow
arrow

+23%

0.03
vs 0.02

Q4.24

arrow
arrow

+365%

0.02
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+12%

215.7M  vs 192.9M

Q4.22

arrow
arrow

+7%

213.9M  vs 199.2M

Q1.23

arrow
arrow

+15%

231.6M  vs 201.9M

Q2.23

arrow
arrow

+19%

255M  vs 214.7M

Q3.23

arrow
arrow

+17%

252M  vs 215.7M

Q4.23

arrow
arrow

-3%

207.5M  vs 213.9M

Q1.24

arrow
arrow

+9%

253.3M  vs 231.6M

Q2.24

arrow
arrow

-1%

253.6M  vs 255M

Q3.24

arrow
arrow

-6%

236.5M  vs 252M

Q4.24

arrow
arrow

-5%

197.6M  vs 207.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.04

Q4.22

arrow
arrow

+2%

0.02
vs 0.04

Q1.23

arrow
arrow

+3%

0.03
vs 0.02

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+3%

0.03
vs 0.04

Q4.23

arrow
arrow

-1%

-0.01
vs 0.03

Q1.24

arrow
arrow

+4%

0.04
vs -0.01

Q2.24

arrow
arrow

+6%

0.06
vs 0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News